Related Experiment Video

Updated: Jul 11, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

[Role of RASSF1A hypermethylation in prostate cancer]

Yu-cai Wang1, Zheng-hong Yu, Long-bang Chen

  • 1Department of Medical Oncology, Nanjing General Hospital of Nanjing Command, PLA, Nanjing, Jiangsu 210002, China.

Zhonghua Nan Ke Xue = National Journal of Andrology
|October 13, 2007
PubMed

Insights

Aberrant methylation of the RASSF1A gene promoter is a key factor in prostate cancer development. Examining RASSF1A methylation offers potential for early diagnosis and novel therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • The RASSF1A gene, located in the 3p21.3 region, is identified as a significant tumor suppressor.
  • Aberrant methylation of CpG islands within the RASSF1A promoter region is a primary mechanism for its inactivation.
  • This epigenetic alteration is implicated in the pathogenesis of various solid tumors, notably prostate cancer.

Purpose:

  • To investigate the role of RASSF1A gene methylation in prostate cancer.
  • To evaluate the diagnostic potential of RASSF1A methylation status in early prostate cancer detection.
  • To explore the therapeutic implications of targeting RASSF1A methylation.

Summary:

  • RASSF1A gene promoter methylation is a critical event in prostate cancer.
  • Analysis of RASSF1A methylation serves as a valuable biomarker for early prostate cancer diagnosis.
  • Methylation inhibitors represent a promising avenue for novel prostate cancer therapies.

Impact:

  • Highlights RASSF1A methylation as a crucial factor in prostate cancer etiology.
  • Establishes RASSF1A methylation detection as a potential diagnostic tool for early-stage disease.
  • Suggests RASSF1A-targeted therapies, such as methylation inhibitors, for future clinical application.

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...